Results

Total Results: 1,027 records

Showing results for "drug".

241. The Use of Aspirin for Primary Prevention of Colorectal Cancer: A Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/pnyU5fxhdBUtCdvJ3GyqzR
     March 01, 2007 - Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women. … Nonsteroidal antiinflammatory drug use Clinical Guidelines Aspirin for Primary Prevention of Colorectal … Pharmacoepidemiol Drug Saf. 1998;7:99-106. [PMID: 15073733] 57. Bartolucci AA, Howard G. … 000), frequency-matched by sex and age to case-patients Nonaspirin NSAIDs and aspirin (prescription drug … � NHANES I Epidemiologic Follow-up Study; NR � not reported; NSAID � nonsteroidal anti-inflammatory drug

242. Archived: Evidence Summary: Aspirin: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
     March 15, 2007 - Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women. … Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma. … Pharmacoepidemiol Drug Saf 1998;7:99-106. [PMID: 15073733] Bartolucci AA, Howard G. … Nonsteroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis … = NHANES I Epidemiologic Follow-up Study; NR = not reported; NSAID = nonsteroidal anti-inflammatory drug

243. Archived: Evidence Summary: Dementia in Older Adults: Screening, 2003 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/dementia-older-adults-screening-2003
     June 03, 2003 - Food and Drug Administration-approved cholinesterase inhibitors to placebo among people with mild to … the dropout rate attributable to adverse events in participants ranged from 2% to 15% higher in the drug … Review of outcome measurement instruments in Alzheimer's disease drug trials: introduction. … Food and Drug Administration; 1989. 112. Roman GC. … 3 to 12 Months Drug

244. Final Research Plan: Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/unhealthy-alcohol-use-adolescents-adults-behavioral-counseling-interventions
     May 16, 2024 - Studies in which the only aim is targeting another behavior (e.g., drug or tobacco use) such that change … Scale) Meeting criteria for alcohol use disorder Other risky behaviors (e.g., other illicit drug

245. Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women (pdf file)
     www.uspreventiveservicestaskforce.org/Home/GetFileByID/2316
     September 01, 2015 - Food and Drug Administration (FDA)-approved smoking cessation medications. … Food and Drug Administration has approved several medications and NRT products, including: … Food and Drug Administration (FDA)–approved pharmacotherapy for cessation to adults who use tobacco

246. Final Research Plan: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan105/latent-tuberculosis-infection-screening
     September 25, 2014 - hepatitis), mortality from hepatotoxicity, nausea, vomiting, peripheral neuropathy, development of drug-resistant … diabetes, persons who have previously received the Bacillus Calmette–Guérin (BCG) vaccination, injection drug … facilities, correctional institutions, long-term care facilities for the elderly, homeless shelters, and drug

247. Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women (pdf file)
     www.uspreventiveservicestaskforce.org/Home/GetFileByToken/-Q3NPMfynb-gm2v3sH4cdD
     September 01, 2015 - Food and Drug Administration (FDA)-approved smoking cessation medications. … Food and Drug Administration has approved several medications and NRT products, including: … Food and Drug Administration (FDA)–approved pharmacotherapy for cessation to adults who use tobacco

248. Archived: Final Research Plan: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan105/latent-tuberculosis-infection-screening-september-2016
     September 25, 2014 - hepatitis), mortality from hepatotoxicity, nausea, vomiting, peripheral neuropathy, development of drug-resistant … diabetes, persons who have previously received the Bacillus Calmette–Guérin (BCG) vaccination, injection drug … facilities, correctional institutions, long-term care facilities for the elderly, homeless shelters, and drug

249. Archived: Final Research Plan: Depression in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan15/depression-in-children-and-adolescents-screening
     September 15, 2013 - care setting (e.g., mental health specialty settings) Inpatients or those in residential or drug … setting (e.g., mental health specialty settings) Inpatients or those in residential treatment or drug … Human Development Index of low to high KQs 5, 6: Inpatients or those in residential or drug

250. Evidence Summary: Screening for Dyslipidemia in Younger Adults: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-dyslipidemia/statin-use-in-adults-preventive-medication
     November 13, 2016 - What are the benefits of dyslipidemia treatment (such as drug or lifestyle interventions) in adults aged … What are the harms of drug treatment of asymptomatic dyslipidemia in adults aged 21 to 39 years? … contextual questions (not reviewed systematically): 1 on how intermediate outcomes are affected by drug … Regarding treatment, both drug therapy and lifestyle interventions (such as exercise and diet changes … As detailed in the full report, we also found no evidence regarding the effects of drug treatment of

251. Archived: Evidence Summary: Screening for Dyslipidemia in Younger Adults: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-dyslipidemia/statin-use-in-adults-preventive-medication-november-2016
     November 13, 2016 - What are the benefits of dyslipidemia treatment (such as drug or lifestyle interventions) in adults aged … What are the harms of drug treatment of asymptomatic dyslipidemia in adults aged 21 to 39 years? … contextual questions (not reviewed systematically): 1 on how intermediate outcomes are affected by drug … Regarding treatment, both drug therapy and lifestyle interventions (such as exercise and diet changes … As detailed in the full report, we also found no evidence regarding the effects of drug treatment of

252. Evidence Summary: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/lipid-disorders-in-children-screening
     July 18, 2023 - Nonstatin-drug trials showed statistically significant lowering of lipid levels in FH populations, but … few studies were available for any single drug. … Harms reported in the short-term drug trials were similar in the intervention and control groups. … to −29.2]) and LDL-C (MD in change, −37.5 mg/dL [95% CI, −48.0 to −27.0]) compared with the single-drug … The nonstatin-drug trials show reductions in 1 or more lipid parameters and are generally associated

253. U.S. Preventive Services Task Force Announces Appointment of Two New Members | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/us-preventive-services-task-force-announces-appointment-two-new-members-2
     December 16, 2016 - U.S. Preventive Services Task Force Announces Appointment of Two New Members Share to Facebook Share to X Share to WhatsApp Share to Email Print 12/16/2016 – The U.S. Preventive Services Task Force announced today the addition of two new memb…

254. Evidence Summary: Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions
     January 19, 2021 - systematic reviews that the combination of pharmacotherapy and behavioral support, all 7 US Food and Drug … for varenicline, 2.24 (95% CI, 2.06-2.43; 27 trials; n = 12,625) 16 when compared with placebo or no drug … report on smoking cessation. 2 There is moderate to high-certainty evidence that all 7 US Food and Drug … partners (Centers for Disease Control and Prevention, National Institutes of Health, and US Food and Drug … Pharmacoepidemiol Drug Saf . 2020;29(1):94-102. doi:10.1002/pds.4894 114.

255. Archived: Final Evidence Summary: Syphilis Infection in Pregnancy: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary94/syphilis-infection-in-pregnancy-screening-2009
     May 15, 2009 - Procedural Terminology code; or procedural code for anaphylactic shock, unspecified adverse effect of drug … received was 0.1 per 10,000 dispensings; resuscitation, 0.2 per 10,000 dispensings; adverse effect of drug … Drug Saf 2007;30:705-13. [PMID: 17696583] Puhó EH, Szunyogh M, Métneki J, Czeizel AE. … Drug treatment during pregnancy and isolated orofacial clefts in Hungary. … Puhó et al, 2007 13 Case-control To evaluate possible association between drug treatment

256. Screening for Cognitive Impairment in Older Adults: Clinical Summary of USPSTF Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/nKXBrHEeNwh37DFKTXapt8
     March 18, 2014 - Food and Drug Administration include acetylcholinesterase inhibitors and memantine.

257. Final Research Plan: Aspirin to Prevent Cardiovascular Disease: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan-aspirin-to-prevent-cardiovascular-diseas/aspirin-to-prevent-cardiovascular-disease-and-cancer
     October 07, 2013 - factors (including history of gastrointestinal bleeding, ulcers, or nonsteroidal anti-inflammatory drug

258. Archived: Final Research Plan: Aspirin to Prevent Cardiovascular Disease: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan-aspirin-to-prevent-cardiovascular-diseas/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
     October 07, 2013 - factors (including history of gastrointestinal bleeding, ulcers, or nonsteroidal anti-inflammatory drug

259. High-Priority Evidence Gaps For Clinical Preventive Services: 7th Annual Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annual-report-to-congress-2017%20(2).pdf
     January 01, 2017 - Screening for Illicit Drug Use in Children and Adolescents 4. … Men .....................................................................17 Screening for Illicit Drug … .31 Illicit drug use includes the abuse of illegal drugs and the misuse of prescription medications … Drug Use. … Food and Drug Administration–approved pharmacotherapy for cessation to adults who use tobacco.

260. Archived: Evidence Summary: Obesity in Adults: Screening and Counseling, 2003 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-adults-screening-and-counseling-2003
     December 15, 2003 - Primary adverse drug effects included hypertension with sibutramine (mean increase: 0.0-3.5 mm Hg) and … Medical Journal's Clinical Evidence . 31 We used the last as the sole systematic review source for drug … Effects of drug treatment for obesity in adults. Clin Evid 2001;412-19. 32. … Drug treatment of obesity. … : 46 Drug, L: 41 Drug, D, L: 40 36-39 1 yr Sibutramine + diet + lifestyle -16.6 kg